Robert Stanley Tutag, Director at CORGENIX MEDICAL CORP/CO (CONX), bought 76,000 shares at $0.11 ($8K) on 2010-10-08, disclosed to the SEC on 2010-10-12.
Open-market purchase of $8k CONX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.11 | 20,000 | $2K | 26.3% |
| 2 | $0.11 | 6,000 | $660 | 7.9% |
| 3 | $0.11 | 2,000 | $220 | 2.6% |
| 4 | $0.11 | 3,000 | $330 | 3.9% |
| 5 | $0.11 | 10,000 | $1K | 13.2% |
| 6 | $0.11 | 11,300 |
| $1K |
| 14.9% |
| 7 | $0.11 | 23,700 | $3K | 31.2% |
| Total | $0.11 avg | 76,000 | $8K | 100% |
| Filing → |
| CONX | BUY | 2008-06-03 | $5K | — | Filing → |
| CONX | BUY | 2006-02-28 | $16K | — | Filing → |